NeopharmCO.
네오팜KRX: 092730· Fiscal year 2025· neopharm.co.kr ↗
Average salary
$47.8K
₩63.7M
▲ 14.5% vs 2024
Employees
192
▲ 12.3% vs 2024
Average tenure
4.9 yrs
Estimated take-home of this pay:$3.3K / monthCalculate →
Workplace
Women's pay (men = 100)66
Women among staff52.6%
Contract staff0%
Recent official filings
- 2026-11-13Quarterly report (2026.09)
- 2026-11-09Preliminary earnings
- 2026-08-24Investor relations (IR) event
- 2026-08-14Half-year report (2026.06)
- 2026-08-07Preliminary earnings
Quick read
- Average pay is 4% above the median of the companies we track.
- Average pay rose 14.5% from 2024.
- Headcount grew by 21 (12.3%) from 2024.
- Ranks #176 of 367 Chemicals & Materials companies in this country by pay.
- Revenue grew 11.1% year over year.
- Revenue has grown two years in a row.
- Operating margin was 21.8% in 2025.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $515.5K
- Net profit per employee
- $108.5K
- Operating margin
- 21.8%
- Net margin
- 21.0%
- ROE
- 14.2%
- Debt-to-equity
- 11.5%
- Equity ratio
- 89.7%
- Payout ratio
- 42.2%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.